Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Digital twins for predictive oncology will be a paradigm shift for precision cancer care

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: The Cancer Patient Digital Twin life cycle.


  1. Wilkinson, M. D. et al. Sci. Data 3, 160018 (2016).

    Article  Google Scholar 

  2. Fagnan, K. et al. Data and Models: a Framework for Advancing AI in Science (Office of Scientific and Technical Information, 2019);

  3. Bozkurt, S. et al. J. Am. Med. Inform. Assoc. 27, 1878–1884 (2020).

    Article  Google Scholar 

  4. Kapteyn, M. G., Pretorius, J. V. & Willcox, K. E. Nat. Comput. Sci. 1, 337–347 (2021).

    Article  Google Scholar 

  5. Taschuk, M. & Wilson, G. PLoS Comput. Biol. 13, e1005412 (2017).

    Article  Google Scholar 

  6. Zhang, J., Cunningham, J. J., Brown, J. S. & Gatenby, R. A. Nat. Commun. 8, 1816 (2017).

    Article  Google Scholar 

  7. Zou, J. & Schiebinger, L. Nature 559, 324–326 (2018).

    Article  CAS  Google Scholar 

  8. Corbett-Davies, S. & Goel, S. Preprint at (2018).

  9. Hernandez-Boussard, T., Bozkurt, S., Ioannidis, J. P. A. & Shah, N. H. J. Am. Med. Inform. Assoc. 27, 2011–2015 (2020).

    Article  Google Scholar 

  10. Greenspan, E. et al. CAFCW 113 Digital Twins for predictive cancer care: an HPC-enabled community initiative (2019);

Download references


We thank Jeannette Yusko (LLNL) and Janelle Cataldo (LLNL) for their contributions to the development of Fig. 1. This work was supported in part by Lawrence Livermore National Laboratory (LLNL). Lawrence Livermore National Laboratory is operated by Lawrence Livermore National Security, LLC, for the US Department of Energy, National Nuclear Security Administration, under contract DE-AC52-07NA27344. LLNL-JRNL-823517. This work has been supported in part by the Joint Design of Advanced Computing Solutions for Cancer (JDACS4C) program established by the US Department of Energy (DOE) and the National Cancer Institute (NCI) of the National Institutes of Health NIH), Leidos Biomedical Research contract no. 75N91019D00024. T.H.-B., P.M., I.S. and T.S.-M. were supported in part by Cancer Moonshot funds from the National Cancer Institute, Leidos Biomedical Research Subcontract 21X126F. T.H.-B. was supported in part by the National Cancer Institute of the National Institutes of Health under award number R01CA183962. The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. This document was prepared as an account of work sponsored by an agency of the US government. Neither the US government nor Lawrence Livermore National Security, LLC, nor any of their employees makes any warranty, expressed or implied, or assumes any legal liability or responsibility for the accuracy, completeness or usefulness of any information, apparatus, product or process disclosed, or represents that its use would not infringe privately owned rights. Reference herein to any specific commercial product, process, or service by trade name, trademark, manufacturer or otherwise does not necessarily constitute or imply its endorsement, recommendation or favoring by the US government or Lawrence Livermore National Security, LLC. The views and opinions of authors expressed herein do not necessarily state or reflect those of the US government or Lawrence Livermore National Security, LLC, and shall not be used for advertising or product endorsement purposes.

Author information

Authors and Affiliations



T.H.B., P.M., E.G., A.G. and I.S. drafted the manuscript; all authors were responsible for the concept, design and critical revision of the manuscript.

Corresponding author

Correspondence to Tina Hernandez-Boussard.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hernandez-Boussard, T., Macklin, P., Greenspan, E.J. et al. Digital twins for predictive oncology will be a paradigm shift for precision cancer care. Nat Med 27, 2065–2066 (2021).

Download citation

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research